KATHERINE SPEARS: Open Payments
NPI 1326445578 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 67 payments from 17 companies in 2025. Trend: 2023 $1,418 · 2024 $1,153 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $164 |
| GENZYME CORPORATION | 9 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $147 |
| Grifols USA, LLC | 7 | $125 |
| ABBVIE INC. | 4 | $95 |
| CSL Behring | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $45 |
| Lilly USA, LLC | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Amgen Inc. | 2 | $29 |
Products named: DUPIXENT, Prolastin-C Liquid, PREVNAR 20, Kcentra, OFEV, JASCAYD, NURTEC ODT, UBRELVY.
Industry payments across AR — which companies pay providers there.
